Skip to main content
SpringerLink
Log in

Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate

  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

The present work was aimed at formulating a SMEDDS (self-microemulsifying drug delivery system) of fenofibrate and evaluating its in vitro and in vivo potential. The solubility of fenofibrate was determined in various vehicles. Pseudoternary phase diagrams were used to evaluate the microemulsification existence area, and the release rate of fenofibrate was investigated using an in vitro dissolution test. SMEDDS formulations were tested for microemulsifying properties, and the resultant microemulsions were evaluated for clarity, precipitation, and particle size distribution. Formulation development and screening was done based on results obtained from phase diagrams and characteristics of resultant microemulsions. The optimized formulation for in vitro dissolution and pharmacodynamic studies was composed of Labrafac CM10 (31.5%), Tween 80 (47.3%), and polyethylene glycol 400 (12.7%). The SMEDDS formulation showed complete release in 15 minutes as compared with the plain drug, which showed a limited dissolution rate. Comparative pharmacodynamic evaluation was investigated in terms of lipid-lowering efficacy, using a Triton-induced hypercholesterolemia model in rats. The SMEDDS formulation significantly reduced serum lipid levels in phases I and II of the Triton test, as compared with plain fenofibrate. The optimized formulation was then subjected to stability studies as per International Conference on Harmonization (ICH) guidelines and was found to be stable over 12 months. Thus, the study confirmed that the SMEDDS formulation can be used as a possible alternative to traditional oral formulations of fenofibrate to improve its bioavailability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci. 2000; 11: S93-S98.

    Article  PubMed  CAS  Google Scholar 

  2. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995; 12: 1561–1572.

    Article  PubMed  CAS  Google Scholar 

  3. Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000; 26: 523–529.

    Article  PubMed  CAS  Google Scholar 

  4. Kang BK, Lee JS, Chona SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004; 274: 65–73.

    Article  PubMed  CAS  Google Scholar 

  5. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994; 106: 15–23.

    Article  CAS  Google Scholar 

  6. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992; 9: 87–93.

    Article  PubMed  CAS  Google Scholar 

  7. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001; 212: 233–246.

    Article  PubMed  CAS  Google Scholar 

  8. Physician’s Desk Reference 2000. 54th ed. Montvale, NJ: Medical Economics Company; 2000: 476–477.

  9. Kasim NA, Whitehouse M, Ramachandran C, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 2004; 1: 85–96.

    Article  PubMed  CAS  Google Scholar 

  10. Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macrocycl Chem. 2006; 56: 247–251.

    Article  CAS  Google Scholar 

  11. Law D, Wang W, Schmitt E, Qiu Y, Krill SK, Fort JJ. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci. 2003; 92: 505–515.

    Article  PubMed  CAS  Google Scholar 

  12. Curtet B, Teillaud E, Reginault P, inventors. Fournier Innovation et Synergie, assignee. Novel dosage form of fenofibrate. US patent 4 895 726. January 23, 1980.

  13. Tricor. fenofibrate [package insert]. North Chicago, IL: Abbott Laboratories. 2002.

    Google Scholar 

  14. Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998; 167: 155–164.

    Article  CAS  Google Scholar 

  15. Zlatkis A, Zak B, Boyle AJ. New method for direct determination of serum cholesterol. J Lab Clin Med. 1953; 41: 486–492.

    PubMed  CAS  Google Scholar 

  16. Foster IB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem. 1973; 19: 338–340.

    PubMed  CAS  Google Scholar 

  17. Groves MJ. The self-emulsifying action of mixed surfactants in oil. Acta Pharm Suec. 1976; 13: 361–372.

    PubMed  CAS  Google Scholar 

  18. Schulman JH, Montagne JB. Formation of microemulsions by amino alkyl alcohols. Ann N Y Acad Sci. 1961; 92: 366–371.

    Article  PubMed  CAS  Google Scholar 

  19. Mei X, Etzler FM, Wang Z. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006; 324: 128–135.

    Article  PubMed  CAS  Google Scholar 

  20. Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm. 1998; 161: 75–86.

    Article  CAS  Google Scholar 

  21. Constantinides PP, Scalart JP. Formulation and physical characterization of water-in-oil microemulsions containing long-versus medium-chain glycerides. Int J Pharm. 1997; 158: 57–68.

    Article  CAS  Google Scholar 

  22. de Campo L, Yaghmur A, Garti N, Leser ME, Folmer B, Glatter O. Five-component food-grade microemulsions: structural characterization by SANS. J Colloid Interface Sci. 2004; 274: 251–267.

    Article  PubMed  CAS  Google Scholar 

  23. Szekeres E, Acosta E, Sabatini DA, Harwell JH. A two-state model for selective solubilization of benzene-limonene mixtures in sodium dihexyl sulfosuccinate microemulsions. Langmuir. 2004; 20: 6560–6569.

    Article  PubMed  CAS  Google Scholar 

  24. Nutting DF, Tso P. Hypolipidemic effects of intravenous pluronic L-81 in fasted rats treated with Triton WR-1339; possible inhibition of hepatic lipoprotein secretion. Horm Metab Res. 1989; 21: 113–115.

    Article  PubMed  CAS  Google Scholar 

  25. Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 1972; 7: 68–74.

    Article  PubMed  CAS  Google Scholar 

  26. Krishnamurthy A, Thapar GS. Effect of benzafibrate and nicotinic acid on Triton-induced hyperlipidemias in CFY rats. Indian J Med Res. 1991; 94: 395–398.

    PubMed  CAS  Google Scholar 

  27. Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw Hill; 2006: 957–958.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Novel Drug Delivery Systems, Department of Pharmaceutical Sciences, University Institute of Chemical Technology, Matunga, 400019, Mumbal, India

    Ashok R. Patel & Pradeep R. Vavia

Authors
  1. Ashok R. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep R. Vavia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pradeep R. Vavia.

Additional information

Published: October 26, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, A.R., Vavia, P.R. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J 9, 41 (2007). https://doi.org/10.1208/aapsj0903041

Download citation

  • Received:

  • Revised:

  • Accepted:

  • DOI: https://doi.org/10.1208/aapsj0903041

Keywords

Search

Navigation